Navigation Links
Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference

d emphysema.

Important Safety Information
Perforomist™ Inhalation Solution belongs to a class of medications known as long-acting beta2-adrenergic agonists (LABAs). LABAs may increase the risk of asthma-related death. Data from a large placebo-controlled US study comparing the safety of another LABA (salmeterol) or placebo added to usual asthma therapy showed an increase in asthma-related deaths in patients receiving salmeterol. This finding with salmeterol may apply to formoterol (a LABA), the active ingredient in Perforomist™ Inhalation Solution.
Perforomist™ Inhalation Solution should not be used in patients with acutely deteriorating COPD or to treat acute symptoms. Acute symptoms should be treated with fast-acting rescue inhalers. Perforomist™ Inhalation Solution should not be used with other medications containing LABAs. Do not use more than one nebule twice daily. Perforomist™ Inhalation Solution should be used with caution in patients with cardiovascular disorders. Perforomist™ Inhalation Solution is not a substitute for inhaled or oral corticosteroids. The safety and efficacy of Perforomist™ Inhalation Solution in asthma has not been established.

In COPD clinical trials, the most common adverse events reported with Perforomist™ Inhalation Solution were diarrhea, nausea, nasopharyngitis, dry mouth, vomiting, dizziness, and insomnia.

About Dey, L.P.
Dey, L.P. is a specialty pharmaceutical company focused on the development, manufacturing and marketing of prescription drug products for the treatment of respiratory diseases, respiratory-related allergies, and emergency care medicine. As the US leader in nebulized respiratory medication, DEY puts patients first through its development of innovative and affordable therapies. The Web sites for DEY include www.dey.com, www.accu
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Genetic Analysis Systems Enter the Clinical Mainstream
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
4. Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
7. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference

Post Your Comments:
(Date:11/25/2009)...RK, Calif., Nov. 25 Praxis Electro...in the American Academy of Family Physicians, (AAF...Satisfaction Survey for improving medical quality,...ritical for new ARRA Stimulus legislation. Praxis ...had a positive effect in determining their salary....
(Date:11/25/2009)..., Colo., Nov. 25 Heska C...of advanced diagnostic and specialty products to...ts with Roche Diagnostics Corporation for the supp...s for the veterinary market. ,, (Logo: htt...O ) ,, "Heska and Roche share the same passion ...
(Date:11/25/2009)... N.J., Nov. 25 Pharmasse...eutical company committed to discovering, developi...infections, reported financial results for the fis..., 2009 Pharmasset held $58.4 million in cash, cash...ipeline Update and 2009 Highlights ,, RG7128 ...
Breaking Medicine Technology:Praxis EMR Wins Top Rankings in 2009 AAFP EHR User Satisfaction Survey 2Heska Announces Supply Agreement With Roche Diagnostics 2Heska Announces Supply Agreement With Roche Diagnostics 3Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8Pharmasset Reports Fiscal Year End 2009 Financial Results 9Pharmasset Reports Fiscal Year End 2009 Financial Results 10The Ambrosia Treatment Centers Awarded Gold Seal of Approval by the Joint Commission 58389 1The Ambrosia Treatment Centers Awarded Gold Seal of Approval by the Joint Commission 58389 2The Ambrosia Treatment Centers Awarded Gold Seal of Approval by the Joint Commission 58389 3Weed Scientists Take Steps to Protect Rare Orchid 14272 1Weed Scientists Take Steps to Protect Rare Orchid 14272 2Weed Scientists Take Steps to Protect Rare Orchid 14272 3Mesothelioma Surgical Update by Dr David Rice MD Anderson Sponsored by MesoCare org 58384 1
...port basic findings on critical enzyme,s regulatio...t an array of disorders , , MEMPHIS, Tenn., N...h Hospital have gained new insights into regulatio...lpains. , , As the cell,s molecular overachi...s, including the movement of cells in tissues, the...
...euroDiscovery Ltd (ASX:,NDL), a specialty neurosci...,and Sosei Group Corporation ("Sosei"; TSE Mothers...utical company, today announce that NeuroSolutions...cy data for NSL-043/SD118.,This investigational dr... has,successfully completed Phase I clinical studi...
Other Medicine Technology:New Insight Into the Controls on a Go-To Enzyme 2New Insight Into the Controls on a Go-To Enzyme 3Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 3
(Date:11/30/2009)..., OAK BROOK, Ill. and PLYMOUTH MEETING, Pa., No...Consortium (UHC) today announced that it has signe...th Meeting, Pa, to offer its academic medical cent...rrent technology research. This agreement will off...cisions. ECRI Institute, an independent nonprofit ...
(Date:11/30/2009)...GO Three decades ago, a study revealed that bever..., prompting a switch by U.S. manufacturers to stay...eeting of the Radiological Society of North Americ...ally unsafe. , "One of the driving factors leadi...U.S. was to eliminate inadvertent swallowing of th...
(Date:11/29/2009)...igures on deaths from cancer in Europe show a stea...994 and 2000-2004. Deaths from all cancers in the ... by nine percent in men and eight percent in women...on. , In a study published online in the cancer...0 November), researchers found that there was an a...
(Date:11/29/2009)...TROIT Using mannequins to teach doctors-in-traini...fective way to improve their skills without compro... study from Henry Ford Hospital. , The study sho...be a valuable tool to improve medical residents, k...some of the more common ultrasound-guided procedur...
(Date:11/29/2009)...l-being, a $1,300 round of treatment equals a $41,...DAY, Nov. 28 (HealthDay News) -- Psychological the...appy than getting a raise or winning a lottery pri...alyzed data on thousands of people who provided in...that the increase in happiness from a $1,329 cours...
Breaking Medicine News(10 mins):Health News:University HealthSystem Consortium and ECRI Institute(R) to Provide Enhanced Health Technology Assessment Services 2Health News:University HealthSystem Consortium and ECRI Institute(R) to Provide Enhanced Health Technology Assessment Services 3Health News:Beverage can stay-tabs pose swallowing risk 2Health News:New figures on cancer in Europe show a steady decline in mortality but big variations 2Health News:New figures on cancer in Europe show a steady decline in mortality but big variations 3Health News:New figures on cancer in Europe show a steady decline in mortality but big variations 4Health News:New figures on cancer in Europe show a steady decline in mortality but big variations 5Health News:Simulated training for ultrasound-guided procedures improves safety without risk to patients 2Health News:Psychotherapy Can Boost Happiness More Than Money: Study 2
...matase inhibitors like anastrozole are more effect...receptor-positive early breast cancer// than tamox...et Oncology" journal. Researchers followed mo... and the drug was well tolerated by patients. ...
...ed the present generation not to be under the wron...n be easily cured//. They said that the anti r... have suffered some of the worst side effects of t... vary depending on the disease and the individual’...
...t are high in nutrition may be the best way to eat...ories//. After studying the dietary details of abo...ate more of fruits, vegetables and grains were lik...nt was much less than those who ate richer food. ...
...n made more specific to cancer tumor cells in addi... Mayo Clinic researchers working with colleagues i... safety feature for viruses used to treat cancer. ...fect, the Mayo Clinic virus makeover uses proteins...
...ely people follow dietary recommendations containe... MyPyramid have been deveoped by researchers at th...ng children's adherence to the recommendations dec... to dietary recommendations and to use it to asses...
...e common insecticide permethrin can reduce the cha...ew study.// The conclusion was arrived at aft...Health Research Center in Nairobi and other resear...ds have more than one treated net, reported the on...
Other Medicine News:Health News:Safety of Cancer Therapeutic Viruses Enhanced 2Health News:Adherence to Dietary Recommendations Measured 2Health News:Adherence to Dietary Recommendations Measured 3
Freshlook Colorblends
Acuvue 2 Colours
... Vasculight SR improves the appearance of photo-ag... most benign brown pigments, telangiectasias, and ...n of intense pulsed light (IPLTM) treats pigmenta...nation. The unique, combined approach of IPL and t...
Wildeyes X-Colors
Medicine Products: